Literature DB >> 10813335

Pelvic neuroblastoma: low mortality and high morbidity.

A Cruccetti1, E M Kiely, L Spitz, D P Drake, J Pritchard, A Pierro.   

Abstract

BACKGROUND/
PURPOSE: Cervical, thoracic, and pelvic neuroblastomas are regarded as having a better outcome than abdominal primaries. The aim of the study was to analyze the results of treatment of pelvic neuroblastomas in our institution.
METHODS: The authors reviewed the records of 284 patients with neuroblastoma treated in our hospital during the period 1983 through 1998 and identified 17 (6%) with pelvic tumors. The revised International Neuroblastoma Staging System was used.
RESULTS: There were 6 patients with stage 1 disease, 8 with stage 2, 2 with stage 3, and 1 with stage 4 disease. Intraspinal extension of the tumor was present in 7 patients (41%). Except for one child with stage 4 disease, all patients underwent an attempt of tumor excision, and 6 had a complete resection. All 7 patients with intraspinal tumor survived. Permanent postoperative neurological complications occurred in 6 patients (35%). These included sciatic nerve palsy, urinary and fecal incontinence, neuropathic bladder, and leg weakness or nerve root injury L4-S1. Three of 17 patients died, but 1 fatality was unrelated to the tumor. The overall survival rate was 82% and was not influenced by the completeness of tumor resection.
CONCLUSIONS: The survival of nonmetastatic pelvic neuroblastoma in our institution is good despite incomplete tumor resection. Intraspinal extension is not a negative prognostic factor. Considering the high incidence of permanent neurological damage after surgery and the generally favorable biological characteristics of these tumors, surgical treatment should not be overaggressive.

Entities:  

Mesh:

Year:  2000        PMID: 10813335     DOI: 10.1053/jpsu.2000.6076

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

1.  Infantile neuroblastoma of the urinary bladder detected by hematuria.

Authors:  Shin-ichiro Kojima; Minoru Yagi; Kimio Asagiri; Suguru Fukahori; Yoshiaki Tanaka; Shinji Ishii; Nobuyuki Saikusa; Yoshinori Koga; Motomu Yoshida; Daisuke Masui; Naoko Komatsuzaki; Shin-ichiro Nakagawa; Shuichi Ozono; Ken Tanikawa
Journal:  Pediatr Surg Int       Date:  2013-03-31       Impact factor: 1.827

2.  Pediatric sciatic neuropathies: a 30-year prospective study.

Authors:  J Srinivasan; M M Ryan; D M Escolar; B Darras; H R Jones
Journal:  Neurology       Date:  2011-03-15       Impact factor: 9.910

3.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

Review 4.  Late effects on the urinary bladder in patients treated for cancer in childhood: a report from the Children's Oncology Group.

Authors:  Michael Ritchey; Fernando Ferrer; Patricia Shearer; Sheri L Spunt
Journal:  Pediatr Blood Cancer       Date:  2009-04       Impact factor: 3.167

5.  Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma.

Authors:  Wen-Guang He; Yu Yan; Wen Tang; Rong Cai; Gang Ren
Journal:  Oncotarget       Date:  2017-06-06

6.  Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.

Authors:  Hervé J Brisse; Thomas Blanc; Gudrun Schleiermacher; Véronique Mosseri; Pascale Philippe-Chomette; Isabelle Janoueix-Lerosey; Gaelle Pierron; Eve Lapouble; Michel Peuchmaur; Paul Fréneaux; Louise Galmiche; Nathalie Algret; Matthieu Peycelon; Jean Michon; Olivier Delattre; Sabine Sarnacki
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

7.  Neuroblastoma originating from extra-abdominal sites: association with favorable clinical and biological features.

Authors:  Ki Woong Sung; Keon Hee Yoo; Hong Hoe Koo; Ju Youn Kim; Eun Joo Cho; Yeon Lim Seo; Jhingook Kim; Suk Koo Lee
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.